TELA BIO INC (TELA) Stock Price & Overview
NASDAQ:TELA • US8723811084
Current stock price
The current stock price of TELA is 0.5973 USD. Today TELA is up by 5.01%. In the past month the price decreased by -29.47%. In the past year, price decreased by -44.69%.
TELA Key Statistics
- Market Cap
- 26.144M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.82
- Dividend Yield
- N/A
TELA Stock Performance
TELA Stock Chart
TELA Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to TELA. When comparing the yearly performance of all stocks, TELA is a bad performer in the overall market: 94.21% of all stocks are doing better.
TELA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to TELA. TELA has a bad profitability rating. Also its financial health evaluation is rather negative.
TELA Earnings
On March 24, 2026 TELA reported an EPS of -0.16 and a revenue of 20.87M. The company beat EPS expectations (14.09% surprise) and missed revenue expectations (-2.79% surprise).
TELA Forecast & Estimates
11 analysts have analysed TELA and the average price target is 3.52 USD. This implies a price increase of 489.15% is expected in the next year compared to the current price of 0.5973.
For the next year, analysts expect an EPS growth of 27.08% and a revenue growth 15.2% for TELA
TELA Groups
Sector & Classification
TELA Financial Highlights
Over the last trailing twelve months TELA reported a non-GAAP Earnings per Share(EPS) of -0.82. The EPS increased by 41.01% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -47.69% | ||
| ROE | -615.1% | ||
| Debt/Equity | 8.82 |
TELA Ownership
TELA Latest News, Press Relases and Analysis
TELA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| MDLN | MEDLINE INC-CL A | 29.67 | 58.17B | ||
| COO | COOPER COS INC/THE | 14.03 | 13.691B | ||
| ALGN | ALIGN TECHNOLOGY INC | 14.83 | 12.16B | ||
| SOLV | SOLVENTUM CORP | 9.68 | 11.029B | ||
| LNTH | LANTHEUS HOLDINGS INC | 14.09 | 4.917B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 16.34 | 4.023B | ||
| ICUI | ICU MEDICAL INC | 14.9 | 3.045B | ||
| HAE | HAEMONETICS CORP/MASS | 10.57 | 2.641B | ||
| XRAY | DENTSPLY SIRONA INC | 7.93 | 2.323B | ||
| NEOG | NEOGEN CORP | 27.75 | 2.047B | ||
| UFPT | UFP TECHNOLOGIES INC | 18.84 | 1.48B | ||
| STAA | STAAR SURGICAL CO | 142.99 | 1.001B | ||
| BVS | BIOVENTUS INC - A | 11.48 | 745.855M |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About TELA
Company Profile
TELA Bio, Inc. is a commercial stage medical technology company, which focuses on the design, development, and market of tissue reinforcement materials. The company is headquartered in Malvern, Pennsylvania and currently employs 209 full-time employees. The company went IPO on 2019-11-08. The firm is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The firm's OviTex products include OviTex 1S, OviTex 2S, OviTex LPR, and OviTex IHR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.
Company Info
IPO: 2019-11-08
TELA BIO INC
1 Great Valley Parkway, Suite 24
Malvern PENNSYLVANIA 19355 US
CEO: Antony Koblish
Employees: 209
Phone: 13026587581
TELA BIO INC / TELA FAQ
Can you describe the business of TELA BIO INC?
TELA Bio, Inc. is a commercial stage medical technology company, which focuses on the design, development, and market of tissue reinforcement materials. The company is headquartered in Malvern, Pennsylvania and currently employs 209 full-time employees. The company went IPO on 2019-11-08. The firm is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The firm's OviTex products include OviTex 1S, OviTex 2S, OviTex LPR, and OviTex IHR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.
Can you provide the latest stock price for TELA BIO INC?
The current stock price of TELA is 0.5973 USD. The price increased by 5.01% in the last trading session.
Does TELA stock pay dividends?
TELA does not pay a dividend.
What is the ChartMill technical and fundamental rating of TELA stock?
TELA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
When does TELA BIO INC (TELA) report earnings?
TELA BIO INC (TELA) will report earnings on 2026-05-06.
What is the Short Interest ratio of TELA BIO INC (TELA) stock?
The outstanding short interest for TELA BIO INC (TELA) is 1.46% of its float.